NEUCA S.A. (WSE:NEU)

Market Cap	3.23B +0.2%
Revenue (ttm)	13.83B +8.0%
Net Income	175.55M +20.1%
EPS	38.31 +19.1%
Shares Out	4.51M
PE Ratio	18.69
Forward PE	15.92
Dividend	17.80 (2.47%)
Ex-Dividend Date	Jun 29, 2026

Volume	1,033
Open	725.00
Previous Close	716.00
Day's Range	720.00 - 735.00
52-Week Range	645.00 - 857.00
Beta	0.42
Analysts	Strong Buy
Price Target	924.64 (+26.49%)
Earnings Date	May 21, 2026

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1990
• Employees: 5,339
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NEU

Financial Performance

In 2025, NEUCA's revenue was 13.64 billion, an increase of 8.18% compared to the previous year's 12.61 billion. Earnings were 155.58 million, an increase of 0.87%.

Analyst Summary

According to 5 analysts, the average rating for NEU stock is "Strong Buy." The 12-month stock price target is zł 924.64, which is an increase of 26.49% from the latest price.

Price Target

zł 924.64

(26.49% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 16, 2026

Data Sources Report a data error